Markets:

Overview

News

Currencies

International

Treasuries

Psyence Biomedical Ltd. - Common Shares (NQ:PBM)

2.452 -0.088 (-3.46%)

Streaming Delayed Price Updated: 10:01 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Psyence Biomedical Ltd. - Common Shares

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 16, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

May 01, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 25, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 08, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 31, 2025

Via Benzinga

Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein

March 18, 2025

New York, New York--(Newsfile Corp. - March 18, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence Biomed" or the "Company")...

Via Newsfile

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 20, 2024

Via Benzinga

Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket ↗

December 20, 2024

Via Benzinga

US Stocks To Open Lower As Traders Brace For 'Triple Witching' Hour: Analyst Says End Of The Year Recovery 'Would Not Surprise Anyone' ↗

December 20, 2024

U.S. futures declined on Friday, ahead of the 'Triple Witching' hour, which is expected to see $6.6 trillion options expire, for the quarter.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 10, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 09, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 06, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

“Power Nickel (TSX.V: PNPN) (OTCQB: PNPNF) Announces Dividend – MIGI, PRFX, PBM, CSDX Stocks Trending Now!”

December 05, 2024

Via AB Newswire

Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket ↗

December 05, 2024

Via Benzinga

Psyence Biomedical Secures Extension To Meet Nasdaq Compliance Standards ↗

November 20, 2024

Psyence Biomed secures Nasdaq extension to meet compliance by December 31, advancing psilocybin-based therapeutics for mental health treatments.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 07, 2024

Via Benzinga

10 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 09, 2024

Via Benzinga

Psychedelic Biotech Psyence Grows Pipeline With Trials And Psilocybin Drug Developer Acquisition ↗

September 16, 2024

Psyence Biomed launches Phase IIb trials for psilocybin in palliative care and Alcohol Use Disorder, bolstering its clinical pipeline with key acquisitions and partnerships.

Via Benzinga

Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket ↗

September 16, 2024

Via Benzinga

Psyence Biomed Launches First Trial Site In Australia For Phase IIb Psilocybin Study In Palliative Care ↗

September 09, 2024

Psyence Biomed initiates a Phase IIb psilocybin trial in Australia to explore its potential as a treatment for Adjustment Disorder.

Via Benzinga

Crude Oil Down 1%; Dollar Tree Shares Tumble After Downbeat Earnings ↗

September 04, 2024

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.